Ken Kobayashi, MD, FACP, accomplished oncologist, clinical pharmacologist, and senior global life sciences executive, joins the Medical Scientific Advisory Board (“MSAB”), expanding its expertise in drug development.
Rose Higgins to Lead Strategic and Day-to-Day Operations, Driving the Next Stage of Growth.
Dr.Evidence™ Partners with MedShr™ to Enhance Medical Knowledge for Physicians and Healthcare Professionals (HCPs)
Doctor Evidence (DRE) and The Castleman Disease Collaborative Network (CDCN) Announce Collaboration
Doctor Evidence, LLC (“DRE”) Expands Medical Strategy Advisory Board to Strengthen its Artificial Intelligence Solution in Drug Discovery
DRE’s DOC Analytics™ Generates First-Ever Automated Network Meta-Analysis with Natural Language Question AI-Powered Search Results
Dr.Evidence™ announces the appointment of Michael J. Klag, MD, MPH to its medical strategy advisory board